The US Food and Drug Administration approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor ...

The director of solid tumor therapy at Stanford Medicine describes how cellular therapies are transforming cancer care.

In a year of pivotal gastroenterology research, these 10 articles were in a class of their own, according to Dr David Johnson ...

For nearly 20 years, antidepressants have carried suicide risk warnings for young people. Now, experts are questioning if the ...

Long COVID appears to be more prevalent in young and middle-aged adults and may not be taken as seriously as in other age ...

Emerging research revealed how inhaled microplastics may harm respiratory health, with evidence of inflammation, lung lesions ...

The Food and Drug Administration (FDA) has added a boxed warning about liver injury to fezolinetant (Veozah), a drug often ...

Oncologists want definitive guidance on whether patients with resectable NSCLC benefit from immunotherapy before and after ...

Promising early results from an ongoing randomized, open-label, single-arm, Phase 3 study could pave the way for a Pfizer ...

Patients with vitiligo are often told nothing can be done, but even severe disease is potentially treatable, a recent ...

Moderate and high doses of vitamin D3 daily for 5 years didn’t reduce the risk for type 2 diabetes in healthy older adults ...

By 2040, alcohol-associated and metabolic dysfunction–related liver disease will be the leading cause of hepatocellular ...